Formation of new tissue from an arteriovenous loop in the absence of addedextracellular matrix

Citation
Rw. Mian et al., Formation of new tissue from an arteriovenous loop in the absence of addedextracellular matrix, TISSUE ENG, 6(6), 2000, pp. 595-603
Citations number
23
Categorie Soggetti
Cell & Developmental Biology
Journal title
TISSUE ENGINEERING
ISSN journal
10763279 → ACNP
Volume
6
Issue
6
Year of publication
2000
Pages
595 - 603
Database
ISI
SICI code
1076-3279(200012)6:6<595:FONTFA>2.0.ZU;2-P
Abstract
A major requirement for the microsurgical repair of contour defects of the skin, for example, following removal of a skin cancer on the face, is a mas s of vascularised subcutaneous tissue. Such tissue can be generated irt viv o using basic tissue engineering principles. In previous studies in our lab oratory, we have used a model comprising an arteriovenous (AV) shunt loop s andwiched in artificial dermis, placed in a cylindrical plastic growth cham ber, and inserted subcutaneously to grow new connective tissue progressivel y up to 4 weeks. To learn more about the basic growth characteristics with this model, the same AV shunt loop within a chamber without added extracell ular matrix was inserted subcutaneously into the groins of rats for 2, 4, o r 12 weeks (n = 5 per group). There was a progressive increase in the mass and volume of tissue such that the chamber was two-thirds full after 12 wee ks. Histological examination showed that at 2 weeks there was evidence of f ibroblast and vascular outgrowth from the AV shunt, with the formation of g ranulation tissue, surrounded by a mass of coagulated exudate. At 4 weeks t he connective tissue deposition was more extensive, with a mass of more mat ure granulation tissue containing considerable collagen. By 12 weeks there was an extensive, well vascularized mass of mature fibrous tissue. The bloo d vessels and residual adventitia of the AV shunt were the likely source of growth factors and of the cells which populated the chamber with new matur ing connective tissue. A patent AV shunt in an isolated chamber appears to be the minimal requirement for the generation of new vascularized tissue th at is potentially suitable for microsurgical transplantation.